Latest Advisories

  • FDA Advisory No. 2015-021 || The Food and Drug Administration (FDA) is now Online through the BancNet for Clients Online Payment

     

  • FDA Advisory No. 2015-020 - A || Babala sa Publiko Tungkol sa Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot

  • FDA Advisory No. 2015-020 || Public Health Warning Against the Use of the Following Unregistered Products

  • FDA Advisory No. 2015-019 || Public Warning Against the Use of the following Unregistered Drug Products

  • FDA Advisory No. 2015-019-A || Babala sa Publiko Tungkol sa Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot

 

    The FDA Director General, Dr. Kenneth Y. Hartigan-Go, joined the Philippine Delegates to the 67th World Health Assembly (WHA)1, led by the Secretary of Health Dr.  Enrique T. Ona and Ambassador Cecilia B. Rebong (Geneva) as co-leader.  More than 3,000 delegates from the WHO’s 194 Member States convened at the Palais des Nations in Geneva, Switzerland from May 19 to 24 in addressing key global health issues.

      The Health Secretary addressed the Assembly during the plenary debate on the relationship between climate and health, and he remarked that health is one of the most visible dimensions of climate change. He said that the health impacts of climate change are diverse and real, and that a united front against the health impacts of climate change is needed to achieve Universal Health Care (UHC) for the people.

      The delegates actively participated in meetings that adopted more than 20 resolutions on public health issues and approved a number of resolutions on issues, such as regulatory systems strengthening, access to essential medicines, AMR, public health impacts of exposure to mercury, renewed commitments to UHC, health development agenda post-2015, and health intervention and technology assessment in support of UHC, and attended various side events during the week-long conference.  

 The Philippine delegation also included Deputy Permanent Representative Noralyn Baja (Geneva), Dr. Jaime Lagahid, DOH Chief of Staff, Dr. Roland Cortez, DOH Asst. Secretary, Dr. Irma Asuncion, DPCB Director, Dr. Jose R. Llacuna, Jr., CHD-8 Director, 3rd Secretary Sharon Johnnette Agduma of the Philippine Mission (Geneva), Dr. Cirilo R. Galindez, Chief of EVRMC, Attache Michelle Eduarte (Geneva), Dr. Oscar Gutierrez, OIC-PPO, FDA, Dr. Allan Evangelista, BIHC Chief HPO, Dr. Cherylle Gavino, DOH Secretary Executive Assistant, Dr. Linda Milan, DOH Consultant, and Mr. Roger P. Tong-An, PNA National President.

 The Philippines DOH remains committed to continue and sustain its efforts in ensuring equitable, sustainable and quality health for Filipinos. Ambassador Rebong reiterated her “continued support for the work and programs of the WHO and will continue to work with the WHO in addressing global health issues,”

 

1http://www.dfa.gov.ph/index.php/2013-06-27-21-50-36/phl-embassies-and-consulates/3021-phl-joins-more-than-3-000-delegates-in-addressing-key-global-health-issues-at-67th-world-health-assembly

 During the 51st Anniversary celebration on June 23, 2014, FDA Director General Dr. Kenneth Y. Hartigan-Go, and CHD-XI Director Abdullah B. Dumama signed a Memorandum of Agreement, which would allow the FDA to use a portion of the land at the CHD-XI Office in Davao City to build the P30M FDA Regulatory Field Office in Mindanao.

The momentous event was witnessed by the FDA Deputy Director General, Dr. Ariel Valencia and the OIC of the FDA Lega Support Services Center, Atty. Donna Sanchez, together with other member of the FDA Management Team and representatives of the Cebu and Davao Satellite Laboratories.

 Assistant Secretary Romulo A. Busuego, the DOH Mindanao Cluster Head, sent his message of full support to the FDA-CHD-XI Project in Davao City. The eventual presence of the FDA, as health regulatory agency, in Mindanao would be help ensure that the people, especially the uderprivileged, have adequate and equitable access to health products, facilities and services, and will help support the government's efforts to sustained long-term economic growth and poverty reduction, as well as peace and order in the region.

Announcement

  • Second Meeting on the Regulation of Finished Paint Products

    ANNOUNCEMENT

    To      : All Concerned Paint Stakeholders

    From    : Center for Cosmetics Regulation and Research (CCRR)

    Subject : Second Meeting on the Regulation of Finished Paint Products

    In the Interest of service, the Center for Cosmetics Regulation and Research (CCRR) shall conduct a second meeting on the regulation of finished paint products to further discuss regulatory measures involving household/urban hazardous substances (HUHS), particularly paint products, with the following details:

    Date : 27 March 2015
    Time : 1:00 PM
    Venue : CDRRHR (Formerly BHDT) Conference Room
               Building 24, Department of Health
               San Lazaro Compound, Rizal Avenue, Sta. Cruz, Manila

    All concerned paint stakeholders are invited to attend. Registration by e-mail at This email address is being protected from spambots. You need JavaScript enabled to view it. or This email address is being protected from spambots. You need JavaScript enabled to view it. is on a first-come, first-serve basis and only twenty (20) participants (one representative per company) will be accommodated for this activity

    For your information and guidance.

  • Request for Rescheduling of Appointment/Submission

    ANNOUNCEMENT

    Date : 20 March 2015

    To : All FDA-Regulated Establishment Applying for License to Operate (LTO), Certificate of Product Registration (CPR), and Other Authorizations Following the Public Assistance, Information and Receiving (PAIR) Process.

    Subject : Request for Rescheduling of Appointment/Submission

    Effective 16 April 2015, request for rescheduling of appointment for the submission of License to Operate, Certificate of Product Registration, and Other Authorizations following the PAIR Process should be coursed thru the e-mail account: This email address is being protected from spambots. You need JavaScript enabled to view it. following the hereunder format -

    To : This email address is being protected from spambots. You need JavaScript enabled to view it.
    Subject : Rescheduling of Appointment, 14-digit DTN
    Body: Application type (initial, renewal,re-application, etc.); for renewal application, please indicate expiry/validity
    date of current LTO/CPR

    The PAIR Unit will grant request for another appointment schedule only once, thus, applicant companies are advised to prepare all requirement, i.e. documentary, technical and financial, before sending an e-mail request. Further, to avoid inconveniences and payment of surcharge, applicants are highly encouraged to file renewal application as prescribed by existing regulations.

    For your information, guidance and compliance

  • National Consultation for Adoptation and Implementation of the Association of Southeast Asian Nations (ASEAN) Traditional Medicines and Health Supplements (TMHS) Guidelines for Davao

    Due to flight availability, the national consultation to discuss the upcoming adoptation and implementation of the Association of Southeast Asian Nations (ASEAN) Traditional Medicines and Health Supplements (TMHS) Guidelines for Davao on 18 March 2015 is rescheduled from 9:00 AM to 12:00 NN to 1:00 PM - 4:00 PM.

    For more information kindly coordinate with Regional Filed Office XI

    For your information, guidance, and compliance

  • Scheduled Delay in Processing of Electronic Cosmetic Product Notification

    ANNOUNCEMENT

    TO : All Cosmetics Manufacturer, Traders, Distributors and other concerned parties
    DATE : 19 November 2014
    SUBJECT : Scheduled Delay in Processing of Electronic Cosmetic Product Notification
                                         (Cosmetic e-Notification)
  • QPIRA ID for Release

    ANNOUNCEMENT

    DATE        : 10 November 2014
    TO            : ALL REGISTERED QUALIFIED PERSON IN
    INDUSTRY REGULATORY AFFAIRS (QPIRA)
    FROM        :  ATTY. RONALD R. DE VEYRA, MBA, CESO VI
     Acting Deputy Director General - AFO
    SUBJECT   : QPIRA ID for Release

Videos

  • Win the War Against AMR

    The misuse of antibiotics is creating resistant "superbugs" that may leave you or your family without effective treatment the next time antibiotics are needed.

  • FDA Public Assistance Information and Receiving (PAIR) Video Tutorial

    A step by step guide to filing an application for a License to Operate or a Certificate of Product Registration.
    By: Nicole Melanie Molera

  • Dr. Kenneth Hartigan-Go on Responsible Pharmaceutical Manufacturing by Interphil

    Dr. Kenneth Hartigan-Go talks about importance of CGMP in manufacturing pharmaceutical products, bioequivalence, importance of adverse drug monitoring, and ethical marketing communications.

Share Us on

Submit to FacebookSubmit to Google BookmarksSubmit to Twitter